Description
NATIONAL BACKORDER DRUG GEMFIBROZIL
First action · last action
2009-12-03 · 2009-12-03
Transactions
1
First transaction's obligation
$23,850
Base + all options value (sum of deltas)
$23,850
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-12-03+$23,850= $23,850
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-12-03 | +$23,850 | $23,850 | NATIONAL BACKORDER DRUG GEMFIBROZIL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DQAQYBV4FLQ3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77022P0286 | NATIONAL CMOP OFFICE (36C770) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $95,079 | FY2022 |
| 36C26121P1435 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $15,079 | FY2021 |
| 36C77021P0552 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36C77021P0419 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $13,101 | FY2021 |
| 36C77021P0394 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $49,905 | FY2021 |
| 36C77021P0158 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $63,788 | FY2021 |
Other recipients under 6505 from 549-DALLAS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25716P0113 | MCKESSON CORPORATION | 549-DALLAS | $11,630 | FY2016 |
| VA25716P0178 | MICROGENICS CORPORATION | 549-DALLAS | $109,260 | FY2016 |
| VA25715J2597 | GRIFOLS BIOLOGICALS LLC | 549-DALLAS | $129,005 | FY2015 |
| VA25715C0028 | BARD PERIPHERAL VASCULAR, INC. | 549-DALLAS | $11,400 | FY2015 |
| VA25714J3693 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 549-DALLAS | $7,512 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA549P08226_3600_-NONE-_-NONE- · retrieved 2026-09-26.